Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, Omicron, Are Associated with Escape from ADG20 Neutralization In Vitro
Go back to Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, Omicron, Are Associated with Escape from ADG20 Neutralization In Vitro| The Allied Defense Group, Inc. (NASDAQ: ADGI) | Delayed: 4.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.64 | 52 Week High | $3.75 | |||
| Open | $11.45 | 52 Week Low | $2.90 | |||
| Day High | $4.64 | P/E | N/A | |||
| Day Low | $4.64 | EPS | $-3.12 | |||
| Volume | 28,125 | |||||
